Cardiovasc Prev Pharmacother.  2021 Jul;3(3):47-53. 10.36011/cpp.2021.3.e8.

Characteristics of Patients with Vasospastic Angina in Korea: Data from a Large Cohort (VA-KOREA)

• Kim SE
• Jo SH
• Seo WW
• Lee MH
• Kim HJ
• Cho SS
• Lee KY
• Kim DS
• Yang TH
• Her SH
• Han SH
• Lee BK
• Ahn Y
• Rha SW
• Gwon HC
• Choi DJ
• Baek SH

• KMID: 2536940
• DOI: http://doi.org/10.36011/cpp.2021.3.e8

Abstract

The Variant Angina Korea (VA-KOREA) registry is a nationwide prospective multicenter registry designed to reflect the real-world clinical data of Korean patients with vasospastic angina (VSA). A total of 2,960 patients with chest pain and presumed VSA who underwent coronary angiography (CAG) and an ergonovine provocation test were enrolled. The primary endpoint composite of death from any cause, acute coronary syndrome, and newonset symptomatic arrhythmia during the 3-year follow-up was investigated for patient characteristics, laboratory findings, CAG findings, and medications. This article reviewed the current status of VSA in Korea and new findings from VA-KOREA registries to improve the treatment and prognosis of patients with VSA.

Keyword

Angina pectoris; Angina pectoris, variant; Coronary vasospasm

Reference

1. Ong P, Aziz A, Hansen HS, Prescott E, Athanasiadis A, Sechtem U. Structural and functional coronary artery abnormalities in patients with vasospastic angina pectoris. Circ J. 2015; 79:1431–8.

2. Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill Education;2018.

3. Yasue H, Nakagawa H, Itoh T, Harada E, Mizuno Y. Coronary artery spasm--clinical features, diagnosis, pathogenesis, and treatment. J Cardiol. 2008; 51:2–17.

4. Song JK, Park SW, Kang DH, Hong MK, Kim JJ, Lee CW, Park SJ. Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol. 2000; 35:1850–6.

5. JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). Circ J. 2014; 78:2779–801.

6. Kim HL, Jo SH, Kim HJ, Lee MH, Seo WW, Baek SH. Sex differences in clinical characteristics and longterm outcomes in patients with vasospastic angina: results from the VA-Korea registry, a prospective multi-center cohort. Biol Sex Differ. 2020; 11:66.

7. Lee MH, Jo SH, Kwon S, Park BW, Bang DW, Hyon MS, Baek SH, Han SH, Her SH, Shin DI, Kim SE, Seo WW. Impact of overweight/obesity on clinical outcomes of patient with vasospastic angina: from the vasospastic angina in Korea registry. Sci Rep. 2020; 10:4954.

8. Cho SS, Jo SH, Kim HJ, Lee MH, Seo WW, Kim HL, Lee KY, Yang TH, Her SH, Han SH, Lee BK, Park KH, Rha SW, Gwon HC, Choi DJ, Baek SH. Smoking may be more harmful to vasospastic angina patients who take antiplatelet agents due to the interaction: results of Korean prospective multi-center cohort. PLoS One. 2021; 16:e0248386.

9. Lee SN, Shin DI, Jung MH, Choi IJ, Seo SM, Her SH, Kim PJ, Moon KW, Yoo KD, Baek SH. Impact of cystatin-C level on the prevalence and angiographic characteristics of vasospastic angina in Korean patients. Int Heart J. 2015; 56:49–55.

10. Kim HJ, Jo SH, Lee MH, Seo WW, Baek SH. Hyperthyroidism is associated with the development of vasospastic angina, but not with cardiovascular outcomes. J Clin Med. 2020; 9:3020.

11. Seo WW, Jo SH, Kim SE, Kim HJ, Han SH, Lee KY, Her SH, Lee MH, Cho SS, Kim HL, Baek SH. Admission serum potassium levels and prognosis of vasospastic angina. Sci Rep. 2021; 11:5707.

12. Shin DI, Baek SH, Her SH, Han SH, Ahn Y, Park KH, Kim DS, Yang TH, Choi DJ, Suh JW, Kwon HM, Lee BK, Gwon HC, Rha SW, Jo SH. The 24-month prognosis of patients with positive or intermediate results in the intracoronary ergonovine provocation test. JACC Cardiovasc Interv. 2015; 8:914–23.

13. Kim DW, Her SH, Ahn Y, Shin DI, Han SH, Kim DS, Choi DJ, Kwon HM, Gwon HC, Jo SH, Rha SW, Baek SH. Clinical outcome according to spasm type of single coronary artery provoked by intracoronary ergonovine tests in patients without significant organic stenosis. Int J Cardiol. 2018; 252:6–12.

14. Han SH, Lee KY, Her SH, Ahn Y, Park KH, Kim DS, Yang TH, Choi DJ, Suh JW, Kwon HM, Lee BK, Gwon HC, Rha SW, Jo SH, Ko KP, Baek SH. Impact of multi-vessel vasospastic angina on cardiovascular outcome. Atherosclerosis. 2019; 281:107–13.

15. Jo SH, Sim JH, Baek SH. Coronary plaque characteristics and cut-off stenosis for developing spasm in patients with vasospastic angina. Sci Rep. 2020; 10:5707.

16. Kim SE, Jo SH, Han SH, Lee KY, Her SH, Lee MH, Seo WW, Cho SS, Baek SH. Comparison of calciumchannel blockers for long-term clinical outcomes in patients with vasospastic angina. Korean J Intern Med. 2021; 36:124–34.

17. Lee KY, Shin DI, Her SH, Han SH, Ahn Y, Kim DS, Choi DJ, Kwon HM, Gwon HC, Rha SW, Jo SH, Lim SC, Myong JP, Baek SH. Aspirin has a neutral effect in preventing future cardiovascular events in vasospastic angina. Cardiovasc Prev Pharmacother. 2019; 1:30–42.

18. Cho SS, Jo SH, Han SH, Lee KY, Her SH, Lee MH, Seo WW, Kim SE, Yang TH, Park KH, Suh JW, Lee BK, Rha SW, Gwon HC, Baek SH. Clopidogrel plus aspirin use is associated with worse long-term outcomes, but aspirin use alone is safe in patients with vasospastic angina: results from the VA-Korea registry, a prospective multi-center cohort. Sci Rep. 2019; 9:17783.

19. Seo WW, Jo SH, Kim SE, Han SH, Lee KY, Her SH, Lee MH, Cho SS, Baek SH. Clinical impact of statin therapy on vasospastic angina: data from a Korea nation-wide cohort study. Heart Vessels. 2020; 35:1051–9.

20. Mark DB, Califf RM, Morris KG, Harrell FE Jr, Pryor DB, Hlatky MA, Lee KL, Rosati RA. Clinical characteristics and long-term survival of patients with variant angina. Circulation. 1984; 69:880–8.

21. Lavie CJ, De Schutter A, Parto P, Jahangir E, Kokkinos P, Ortega FB, Arena R, Milani RV. Obesity and prevalence of cardiovascular diseases and prognosis—the obesity paradox updated. Prog Cardiovasc Dis. 2016; 58:537–47.

22. Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol. 1994; 23:352–7.

23. Hong MK, Park SW, Lee CW, Ko JY, Kang DH, Song JK, Kim JJ, Mintz GS, Park SJ. Intravascular ultrasound findings of negative arterial remodeling at sites of focal coronary spasm in patients with vasospastic angina. Am Heart J. 2000; 140:395–401.

24. Park YM, Han SH, Ko KP, Koh KK, Kang WC, Lee K, Shin KC, Suh SY, Ahn TH, Choi IS, Shin EK. Diffuse multi-vessel coronary artery spasm: incidence and clinical prognosis. Int J Cardiol. 2013; 167:398–402.

25. Takagi Y, Yasuda S, Takahashi J, Tsunoda R, Ogata Y, Seki A, Sumiyoshi T, Matsui M, Goto T, Tanabe Y, Sueda S, Sato T, Ogawa S, Kubo N, Momomura S, Ogawa H; Shimokawa H; Japanese Coronary Spasm Association. Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association. Eur Heart J. 2013; 34:258–67.

26. Ahn JM, Lee KH, Yoo SY, Cho YR, Suh J, Shin ES, Lee JH, Shin DI, Kim SH, Baek SH, Seung KB, Nam CW, Jin ES, Lee SW, Oh JH, Jang JH, Park HW, Yoon NS, Cho JG, Lee CH, Park DW, Kang SJ, Lee SW, Kim J, Kim YH, Nam KB, Lee CW, Choi KJ, Song JK, Kim YH, Park SW, Park SJ. Prognosis of variant angina manifesting as aborted sudden cardiac death. J Am Coll Cardiol. 2016; 68:137–45.

27. Fukumoto Y, Yasuda S, Ito A, Shimokawa H. Prognostic effects of benidipine in patients with vasospastic angina: comparison with diltiazem and amlodipine. J Cardiovasc Pharmacol. 2008; 51:253–7.

28. Io K, Minatoguchi S, Nishigaki K, Ojio S, Tanaka T, Segawa T, Matsuo H, Watanabe S, Hattori A, Ueno K, Ono H, Hiei K, Sato H, Morita N, Noda T, Kato T, Kawasaki M, Takemura G, Fujiwara H. Effects of benidipine and some other calcium channel blockers on the prognosis of patients with vasospastic angina. Cohort study with evaluation of the ergonovine coronary spasm induction test. Arzneimittelforschung. 2007; 57:573–81.

29. Park T, Park JY, Rha SW, Seo HS, Choi BG, Choi SY, Byun JK, Park SH, Park EJ, Choi JY, Park SH, Lee JJ, Lee S, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Park CG, Oh DJ. Impact of diltiazem alone versus diltiazem with nitrate on five-year clinical outcomes in patients with significant coronary artery spasm. Yonsei Med J. 2017; 58:90–8.

30. Takahashi J, Nihei T, Takagi Y, Miyata S, Odaka Y, Tsunoda R, Seki A, Sumiyoshi T, Matsui M, Goto T, Tanabe Y, Sueda S, Momomura S, Yasuda S, Ogawa H, Shimokawa H; Japanese Coronary Spasm Association. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association. Eur Heart J. 2015; 36:228–37.

31. Kim KH, Cho SH, Yim YR, Lee KJ, Yum JH, Yoon HJ, Yoon NS, Hong YJ, Park HW, Kim JH, Ahn Y, Jeong MH, Cho JG, Park JC. Effects of low dose versus high dose statin therapy on the changes of endothelial function and carotid intima-media thickness in patients with variant angina. J Cardiovasc Ultrasound. 2013; 21:58–63.

32. Yun KH, Shin IS, Park EM, Rhee SJ, Lee EM, Yoo NJ, Kim NH, Oh SK, Jeong JW. Effect of additional statin therapy on endothelial function and prognosis in patients with vasospastic angina. Korean Circ J. 2008; 38:638–43.